BRCA2 Antibodies

Santa Cruz Biotechnology provides a broad selection of BRCA2 monoclonal antibodies for investigating BRCA2 protein's role in cellular processes. BRCA2 monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BRCA2 is a critical protein involved in the repair of DNA double-strand breaks, playing a vital role in maintaining genomic stability. Mutations in the BRCA2 gene are associated with an increased risk of breast and ovarian cancers, making it a significant focus of cancer research. Understanding the function and regulation of BRCA2 is essential for developing targeted therapies and improving patient outcomes. BRCA2 monoclonal antibodies enable detailed analysis of protein expression patterns across different cell types and tissues. Researchers can examine BRCA2 localization within cellular compartments and study its interactions with other proteins involved in DNA repair pathways. Advanced research with BRCA2 monoclonal antibodies from Santa Cruz Biotechnology continues to drive discoveries in cancer biology and therapeutic development.